Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2021 Feb 2;9(2):e23548.
doi: 10.2196/23548.

WeChat as a Platform for Baduanjin Intervention in Patients With Stable Chronic Obstructive Pulmonary Disease in China: Retrospective Randomized Controlled Trial

Junjie Bi #  1 , Wei Yang #  1 , Ping Hao #  2 , Yongmei Zhao  1 , Dan Wei  1 , Yipeng Sun  1 , Yuhua Lin  1 , Meng Sun  3 , Xuan Chen  3 , Xuming Luo  1 , Shanqun Li  4 , Wei Zhang #  3 , Xiongbiao Wang #  1
Affiliations
Randomized Controlled Trial

WeChat as a Platform for Baduanjin Intervention in Patients With Stable Chronic Obstructive Pulmonary Disease in China: Retrospective Randomized Controlled Trial

Junjie Bi et al. JMIR Mhealth Uhealth. .

Abstract

Background: Pulmonary rehabilitation is a crucial part of the nonpharmacological treatment of stable chronic obstructive pulmonary disease (COPD), but management remains problematic. WeChat could serve as a useful tool in patient management. Baduanjin is a popular exercise in China that is usually applied in pulmonary rehabilitation, which has been confirmed to be effective in improving lung function and life quality.

Objective: This study aimed to explore the efficiency of WeChat in the management of Baduanjin exercise in COPD patients.

Methods: A total of 200 patients from the respiratory department of Putuo Hospital participated in the Baduanjin rehabilitation project from September 2018 to October 2019, and were randomly assigned to the WeChat and control groups and followed up using the WeChat platform or telephone for 12 weeks. The frequency of Baduanjin exercise, lung function (percentage of forced expiratory volume in 1 second predicted, FEV1% predicted), and COPD assessment test (CAT) scores were collected and compared between the two groups. The number of message exchanges and a satisfaction survey on the WeChat platform were used to assess the feasibility of WeChat management outside the hospital.

Results: The Baduanjin exercise frequency significantly differed between the control group and WeChat group (F=33.82, P<.001) and across various time points (F=214.87, P<.001). After the follow-up on WeChat, there were fewer patients not performing Baduanjin exercise. The FEV1% predicted value significantly differed before and after Baduanjin exercise in the control group (Z=-3.686, P<.001) and the WeChat group (Z=-6.985, P<.001). A significant difference in the FEV1% predicted value was observed after Baduanjin exercise between the two groups (Z=-3.679, P<.001). The CAT score significantly differed before and after Baduanjin exercise in the control group (Z=-4.937, P<.001) and the WeChat group (Z=-5.246, P<.001). A significant difference in the CAT score was observed after Baduanjin exercise between the two groups (Z=-5.246, P<.001). The number of completed Baduanjin exercises, lung function, and CAT scores in active patients were higher than those in nonactive patients. All satisfaction survey items were scored with more than 4 points. Among the items, the highest score (mean 4.54, SD 0.77) was for continued WeChat management, followed by the effective management of Baduanjin exercise (mean 4.46, SD 0.87). The patients in the WeChat group showed much higher enthusiasm for and compliance with Baduanjin exercise, resulting in better life quality and lung function. The patients were very satisfied with the WeChat management because of the obvious curative effect and home feeling.

Conclusions: The WeChat platform provided a feasible, effective, and sustainable management plan for Baduanjin rehabilitation.

Trial registration: Chinese Clinical Trial Registry ChiCTR1900028248; http://www.chictr.org.cn/showprojen.aspx?proj=46995.

Keywords: Baduanjin rehabilitation; WeChat management; chronic obstructive pulmonary disease.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: None declared.

Figures

Figure 1
Figure 1
Flowchart of the research design. CAT: chronic obstructive pulmonary disease assessment test; COPD: chronic obstructive pulmonary disease.
Figure 2
Figure 2
Comparison of Baduanjin exercise frequency per week (mean) between the WeChat group and control group (all P<.001).
Figure 3
Figure 3
Lung function before and after Baduanjin exercise. FEV1% pred: percentage of forced expiratory volume in 1 second predicted; ns: not significant. **P<.001.
Figure 4
Figure 4
Chronic obstructive pulmonary disease assessment test (CAT) score before and after Baduanjin exercise. ns: not significant. **P<.001.
Figure 5
Figure 5
Comparison of outcomes between active patients and nonactive patients. (A) Daily exercise frequency; (B) Difference in lung function before and after Baduanjin exercise; and (C) Difference in the chronic obstructive pulmonary disease assessment test (CAT) score before and after Baduanjin exercise. FEV1% pred: percentage of forced expiratory volume in 1 second predicted.**P<.001.
Figure 6
Figure 6
Number of patients with a Baduanjin exercise frequency of 0 (per week) in the WeChat group and control group.
Figure 7
Figure 7
Trend of messages exchanged on WeChat.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Dobler CC, Morrow AS, Beuschel B, Farah MH, Majzoub AM, Wilson ME, Hasan B, Seisa MO, Daraz L, Prokop LJ, Murad MH, Wang Z. Pharmacologic Therapies in Patients With Exacerbation of Chronic Obstructive Pulmonary Disease. Ann Intern Med. 2020 Feb 25;172(6):413–422. doi: 10.7326/M19-3007. - DOI - PubMed
    1. Zhu B, Wang Y, Ming J, Chen W, Zhang L. Disease burden of COPD in China: a systematic review. Int J Chron Obstruct Pulmon Dis. 2018;13:1353–1364. doi: 10.2147/COPD.S161555. doi: 10.2147/COPD.S161555. - DOI - DOI - PMC - PubMed
    1. Fang L, Gao P, Bao H, Tang X, Wang B, Feng Y, Cong S, Juan J, Fan J, Lu K, Wang N, Hu Y, Wang L. Chronic obstructive pulmonary disease in China: a nationwide prevalence study. The Lancet Respiratory Medicine. 2018 Jun;6(6):421–430. doi: 10.1016/S2213-2600(18)30103-6. - DOI - PMC - PubMed
    1. Wedzicha JA, Singh R, Mackay AJ. Acute COPD exacerbations. Clin Chest Med. 2014 Mar;35(1):157–63. doi: 10.1016/j.ccm.2013.11.001. - DOI - PubMed
    1. Vogelmeier CF, Román-Rodríguez M, Singh D, Han MK, Rodríguez-Roisin R, Ferguson GT. Goals of COPD treatment: Focus on symptoms and exacerbations. Respir Med. 2020 May;166:105938. doi: 10.1016/j.rmed.2020.105938. - DOI - PubMed

Publication types